CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | Inquiry & Datasheet |
CAR-WFY2265 | Anti-MLANA (CBFYM-0113) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0113 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2266 | Anti-MLANA (CBFYM-0235) h(41BB-CD3ζ) CAR, pCDCAR1 | Dog, Human, Mouse, Rat | CBFYM-0235 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2267 | Anti-MLANA (CBFYM-0266) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0266 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2268 | Anti-MLANA (CBFYM-0343) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0343 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2269 | Anti-MLANA (CBFYM-0363) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | CBFYM-0363 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2270 | Anti-MLANA (CBFYM-0364) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Dog | CBFYM-0364 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2271 | Anti-MLANA (CBFYM-0427) h(41BB-CD3ζ) CAR, pCDCAR1 | Horse, Human | CBFYM-0427 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2272 | Anti-MLANA (CBFYM-0431) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | CBFYM-0431 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2273 | Anti-MLANA (CBFYM-0432) h(41BB-CD3ζ) CAR, pCDCAR1 | Dog, Human, Mouse, Rat | CBFYM-0432 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2274 | Anti-MLANA (CBFYM-0653) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0653 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2275 | Anti-MLANA (CBFYM-0654) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0654 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2276 | Anti-MLANA (CBFYM-2270) h(41BB-CD3ζ) CAR, pCDCAR1 | Dog, Human | CBFYM-2270 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2277 | Anti-MLANA (CBFYM-2271) h(41BB-CD3ζ) CAR, pCDCAR1 | Dog, Human, Mouse, Rat | CBFYM-2271 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2278 | Anti-MLANA (CBFYM-2272) h(41BB-CD3ζ) CAR, pCDCAR1 | Horse, Human | CBFYM-2272 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2279 | Anti-MLANA (CBFYM-2273) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2273 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2280 | Anti-MLANA (CBFYM-2274) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2274 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2281 | Anti-MLANA (CBFYM-2275) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2275 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2282 | Anti-MLANA (CBFYM-2276) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2276 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2283 | Anti-MLANA (CBFYM-2277) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2277 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2284 | Anti-MLANA (CBFYM-2278) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2278 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2285 | Anti-MLANA (CBFYM-2279) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2279 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2286 | Anti-MLANA (CBFYM-2280) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2280 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY2287 | Anti-MLANA (CBFYM-2281) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2281 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5518 | Anti-MLANA (CBFYM-0113) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0113 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5519 | Anti-MLANA (CBFYM-0235) h(CD28-CD3ζ) CAR, pCDCAR1 | Dog, Human, Mouse, Rat | CBFYM-0235 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5520 | Anti-MLANA (CBFYM-0266) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0266 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5521 | Anti-MLANA (CBFYM-0343) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0343 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5522 | Anti-MLANA (CBFYM-0363) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | CBFYM-0363 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5523 | Anti-MLANA (CBFYM-0364) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Dog | CBFYM-0364 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5524 | Anti-MLANA (CBFYM-0427) h(CD28-CD3ζ) CAR, pCDCAR1 | Horse, Human | CBFYM-0427 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5525 | Anti-MLANA (CBFYM-0431) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | CBFYM-0431 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5526 | Anti-MLANA (CBFYM-0432) h(CD28-CD3ζ) CAR, pCDCAR1 | Dog, Human, Mouse, Rat | CBFYM-0432 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5527 | Anti-MLANA (CBFYM-0653) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0653 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5528 | Anti-MLANA (CBFYM-0654) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0654 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5529 | Anti-MLANA (CBFYM-2270) h(CD28-CD3ζ) CAR, pCDCAR1 | Dog, Human | CBFYM-2270 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5530 | Anti-MLANA (CBFYM-2271) h(CD28-CD3ζ) CAR, pCDCAR1 | Dog, Human, Mouse, Rat | CBFYM-2271 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5531 | Anti-MLANA (CBFYM-2272) h(CD28-CD3ζ) CAR, pCDCAR1 | Horse, Human | CBFYM-2272 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5532 | Anti-MLANA (CBFYM-2273) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2273 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5533 | Anti-MLANA (CBFYM-2274) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2274 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY5534 | Anti-MLANA (CBFYM-2275) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2275 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.
LEARN MOREAngiotensin-converting Enzyme 2 (ACE2)-CHO Cell Line Model for COVID-19: Helps researchers to further study the interaction between the receptor ACE2 and the COVID-19 virus.
LEARN MORETRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.
LEARN MOREThe latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE